A detailed history of Griffith & Werner, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Griffith & Werner, Inc. holds 2,082 shares of ABT stock, worth $272,221. This represents 0.17% of its overall portfolio holdings.

Number of Shares
2,082
Previous 2,080 0.1%
Holding current value
$272,221
Previous $235 Million 17.39%
% of portfolio
0.17%
Previous 0.16%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 14, 2025

BUY
$111.1 - $140.22 $222 - $280
2 Added 0.1%
2,082 $276 Million
Q4 2024

Feb 20, 2025

BUY
$111.93 - $119.39 $232,814 - $248,331
2,080 New
2,080 $235 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $229B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Griffith & Werner, Inc. Portfolio

Follow Griffith & Werner, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Griffith & Werner, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Griffith & Werner, Inc. with notifications on news.